2. Healthcare’s Most Comprehensive Market Intelligence Resources & Advisory Solutions
Health IT
Market Intelligence
Health IT
Insight & Research
Healthcare Organization
Benchmarking
4. Precision Medicine Usage
Precision Medicine usage has
tripled in the last 5 years.
Today 26% of US Hospitals
have procured a Precision
Medicine solution and 22% have
gone live with installation.
The largest volume of installs
has been in the General Medical
market.
5. Precision Medicine Growth
General Medical hospitals make up the
majority of Precision Medicine Installs
because they make up the majority of
US hospitals.
The growth area for Precision
Medicine has been Academic and
Specialty Hospitals which represent
18% of the US market.
Over half of Academic and Specialty
Hospitals have Precision Medicine
technologies in place.
6. Yes
28.5%
Precision Medicine Adoption
2017
vs.
2016
2017 N=100; 2016 N=137
10.3%
10.3%
10.3%
38.5%
30.8%
28.2%
79.5%
4.2%
8.3%
16.7%
16.7%
20.8%
20.8%
29.2%
50.0%
62.5%
0% 20% 40% 60% 80%
Unsure
Other
Epidemiology
Neurology
Prenatal Screening
Endocrinology
Nephrology
Cardiology
Oncology
2017 2016
Similar adoption rates….different mix of focus areas
Yes
26.0%
7. Health System Influence
Health System profit status has
a strong influence on adoption of
Precision Medicine, and cutting
edge technologies in general.
Multi-Hospital Not For Profits
make up the largest portion of
adopters and the largest market
segment.
Precision Medicine is currently
disease state specific with a
difficult to quantify return on
investment.
1,000
Installed
1,000
Not Installed
2,000
Not Installed
2009 2011 2013 2015 2017 2009 2011 2013 2015 2017 2009 2011 2013 2015 2017 2009 2011 2013 2015 2017
n = 5,490
Data from HIMSS Analytics® LOGIC 2017-10-14.
US Hospital Precision Medicine Usage
By health system marker segment
Health System
(Multi): For Profit
Health System
(Multi): Not For
Profit
Health System
(Single): For Profit
Health System
(Single): Not
For Profit
8. Disease Diagnosis, Innovation Leader Primary Drivers
5.1%
12.8%
10.3%
12.8%
15.4%
23.1%
20.5%
4.0%
8.0%
8.0%
12.0%
12.0%
16.0%
20.0%
20.0%
0% 5% 10% 15% 20% 25%
Other
Enhance patient risk assessment
Unsure
Conduct drug therapy monitoring
Conduct clinical drug trials
Become an innovation leader
Enhance disease prevention
Conduct early disease diagnosis
2017 2016
9. Access to Precision Medicine
On average, hospitals that have
adopted Precision Medicine have
twice as many inpatient beds as
those that have yet to adopt.
Just over a third of inpatient beds
are in hospitals with Precision
Medicine capabilities, even though
those hospitals are less than a
quarter of the market.
10. Hub & Spoke Deployment?
Precision
Medicine
expansion via
Health System
networks.
Networks limited
to distances less
than 300 miles.
11. IT Approach Hindering ‘Provider to Genome’ Engagement
Uses
dedicated
precision
medicine
platform AND
in-house
solutions
36%
Uses current
in-house
solutions only
24%
Uses a
dedicated
precision
medicine
platform only
16%
Unsure
16%
Other
8%
Integrating the necessary workflows into
clinical systems.
Integration of the genomic data for use
within the clinical dataset.
Most Significant Challenge:
Data Integration
70%
12. 2017 Vendor Market Share
53% of installs are core
Health IT vendor
38% of installs are
Laboratory vendors
1% of installs are
specialty Precision
Medicine vendors
14. Inflection Points
The strongest indicators
of Precision Medicine
adoption, are adoption
of Laboratory –
Outreach Services and
Anatomical Pathology.
For the top six numerical
predictors, the
distribution of values by
group is overlaid with an
inflection point identified
via eXtreme Gradiant
Boosting.
16. Signals from the noise:
• Precision Medicine is still in its infancy in terms of adoption
• As infrastructure and interoperability mature, the field will expand
beyond disease-specific focus
• Acquisition of Precision Medicine solution vendors are anticipated
to increase over next two years
